N-((1R,2R)-2-hydroxycyclohexyl)-1-methyl-4-(4-(1-methyl-1H-pyrazol-3-yl)benzyl)-1H-pyrrolo[2,3-b]pyridine-6-carboxamide

ID: ALA4246159

Chembl Id: CHEMBL4246159

PubChem CID: 145985065

Max Phase: Preclinical

Molecular Formula: C26H29N5O2

Molecular Weight: 443.55

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1ccc(-c2ccc(Cc3cc(C(=O)N[C@@H]4CCCC[C@H]4O)nc4c3ccn4C)cc2)n1

Standard InChI:  InChI=1S/C26H29N5O2/c1-30-13-11-20-19(15-17-7-9-18(10-8-17)21-12-14-31(2)29-21)16-23(27-25(20)30)26(33)28-22-5-3-4-6-24(22)32/h7-14,16,22,24,32H,3-6,15H2,1-2H3,(H,28,33)/t22-,24-/m1/s1

Standard InChI Key:  QNEDIFOFDSOSLY-ISKFKSNPSA-N

Alternative Forms

  1. Parent:

    ALA4246159

    ---

Associated Targets(Human)

CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Chrm1 Muscarinic acetylcholine receptor M1 (3437 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 443.55Molecular Weight (Monoisotopic): 443.2321AlogP: 3.60#Rotatable Bonds: 5
Polar Surface Area: 84.97Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.22CX LogP: 4.18CX LogD: 4.18
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.49Np Likeness Score: -0.83

References

1. Engers JL, Childress ES, Long MF, Capstick RA, Luscombe VB, Cho HP, Dickerson JW, Rook JM, Blobaum AL, Niswender CM, Engers DW, Conn PJ, Lindsley CW..  (2018)  VU6007477, a Novel M1 PAM Based on a Pyrrolo[2,3-b]pyridine Carboxamide Core Devoid of Cholinergic Adverse Events.,  (9): [PMID:30258541] [10.1021/acsmedchemlett.8b00261]

Source